Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach

被引:0
|
作者
Mahmood, Iftekhar [1 ]
机构
[1] US FDA, Div Hematol Clin Review, OBRR, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA
关键词
Absorption; allometry; clearance; concentration-time; oral drugs; pharmacokinetics; HUMAN PHARMACOKINETICS; DOSE PHARMACOKINETICS; HEALTHY-VOLUNTEERS; PRECLINICAL DATA; SCALE-UP; METABOLISM; CLEARANCE; VENLAFAXINE; EXCRETION; LEVOVIRIN;
D O I
10.2174/13892002186661611211202
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Allometric scaling is regularly used for the prediction of human pharmacokinetic (PK) parameters from animal PK studies. The predicted human PK parameters can also be used for the prediction of plasma concentration-time profiles in humans. Objectives: The main objective of this work is to predict human concentration-time profiles of drugs (one-compartment model) following oral administration using animal oral pharmacokinetic parameters. Methods: Six drugs from the literature were chosen that were described by one-compartment model in both humans and animals following oral administration. Pharmacokinetic parameters such as oral clearance, oral volume of distribution of the central compartment, time to reach maximum plasma concentration, absorption rate constant, and half-life in humans were predicted from animals using allometric scaling. These predicted human pharmacokinetic parameters were then used to predict human plasma concentrations-time profiles of drugs. Results: The results of this study indicate that the proposed method can be used to predict human plasma concentrations-time profiles of drugs with reasonable accuracy (<= 50% prediction error). Conclusions: Given the complexity in the pharmacokinetics of oral drugs there remains some uncertainty in this entire exercise. One can minimize the prediction error by experience in allometric scaling, scientific judgment, and unconventional or innovative thinking.
引用
收藏
页码:1006 / 1013
页数:8
相关论文
共 41 条
  • [21] PHRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 4: Prediction of Plasma Concentration-Time Profiles in Human from In Vivo Preclinical Data by Using the Wajima Approach
    Vuppugalla, Ragini
    Marathe, Punit
    He, Handan
    Jones, Rhys D. O.
    Yates, James W. T.
    Jones, Hannah M.
    Gibson, Christopher R.
    Chien, Jenny Y.
    Ring, Barbara J.
    Adkison, Kimberly K.
    Ku, M. Sherry
    Fischer, Volker
    Dutta, Sandeep
    Sinha, Vikash K.
    Bjornsson, Thorir
    Lave, Thierry
    Poulin, Patrick
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (10) : 4111 - 4126
  • [22] Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function
    Metsugi, Yukiko
    Miyaji, Yoshihiro
    Ogawara, Ken-ichi
    Higaki, Kazutaka
    Kimura, Toshikiro
    PHARMACEUTICAL RESEARCH, 2008, 25 (04) : 886 - 895
  • [23] Comparison of maximum drug concentration and area under the time-concentration curve between humans and animals for oral and intravenous Investigational drugs
    Fujita, T
    Matsumoto, Y
    Ozaki, M
    Majima, M
    Kumagai, Y
    Ohtani, Y
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (06): : 674 - 692
  • [24] A Simple Method for the Prediction of Human Concentration-Time Profiles and Pharmacokinetics of Antibody-Drug Conjugates (ADC) from Rats or Monkeys
    Mahmood, Iftekhar
    ANTIBODIES, 2022, 11 (02)
  • [25] PHRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 5: Prediction of Plasma Concentration-Time Profiles in Human by Using the Physiologically-Based Pharmacokinetic Modeling Approach
    Poulin, Patrick
    Jones, Rhys D. O.
    Jones, Hannah M.
    Gibson, Christopher R.
    Rowland, Malcolm
    Chien, Jenny Y.
    Ring, Barbara J.
    Adkison, Kimberly K.
    Ku, M. Sherry
    He, Handan
    Vuppugalla, Ragini
    Marathe, Punit
    Fischer, Volker
    Dutta, Sandeep
    Sinha, Vikash K.
    Bjornsson, Thorir
    Lave, Thierry
    Yates, James W. T.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (10) : 4127 - 4157
  • [26] Prediction of human bioavailability from human oral administration data and animal pharmacokinetic data without data from intravenous administration of drugs in humans
    Imawaka H.
    Ito K.
    Kitamura Y.
    Sugiyama K.
    Sugiyama Y.
    Pharmaceutical Research, 2009, 26 (8) : 1881 - 1889
  • [27] A novel Css-MRTpo approach to simulate oral plasma concentration-time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite in humans using chimeric mice with humanized livers
    Kamimura, Hidetaka
    Uehara, Shotaro
    Suemizu, Hiroshi
    XENOBIOTICA, 2020, 50 (07) : 761 - 768
  • [28] GENERALIZATIONS IN LINEAR PHARMACOKINETICS USING PROPERTIES OF CERTAIN CLASSES OF RESIDENCE TIME DISTRIBUTIONS .2. LOG-CONCAVE CONCENTRATION-TIME CURVES FOLLOWING ORAL-ADMINISTRATION
    WEISS, M
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1987, 15 (01): : 57 - 74
  • [29] Prediction of in vivo plasma concentration-time profile from in vitro release data of designed formulations of milnacipran using numerical convolution method
    Singhvi, Gautam
    Shah, Abhishek
    Yadav, Nilesh
    Saha, Ranendra N.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (01) : 105 - 108
  • [30] The chemical structure of new substance as the metabolite of baicalin and time profiles for the plasma concentration after oral administration of Sho-Saiko-To in human
    Muto, R
    Motozuka, T
    Nakano, M
    Tatsumi, Y
    Sakamoto, F
    Kosaka, N
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1998, 118 (03): : 79 - 87